Found inside – Page 44Other databases exist that catalog rare diseases. One such database is Orphanet (INSERM, Paris, France) (https://www.orpha.net) which is established in France in 1997 with the purpose of gathering knowledge on rare diseases to improve ... The Orphan Drug Act was passed in 1983 to give drug companies incentives to develop treatments for rare diseases. <> Found insideThe Telethon Suisse (www.telethon.ch) raises funds specifically for rare diseases. Orphanet Switzerland, a partner of the Orphanet rare disease database, is the only specific project for rare diseases supported by the Swiss Conference ... Found inside – Page 13Establishing the diagnosis of a rare pulmonary disease or condition requires the formulation of a comprehensive differential ... States or the European ORPHANET definition of fewer than 1 in 2,000 people (www.orphanet.net) [72]. Found inside – Page 123The World Health Organization (WHO) defines rare diseases (RD) as lifelong, debilitating health conditions that affect 1 ... The Orphanet (www.orpha.net) is a 37country network of information on RDs, with the aim of improving diagnosis, ... This book aims to help all of them to address topics like health care policies, societal issues and clinical and experimental research. In order to contribute to the improvement of the diagnosis, treatment and care of patients, Orphanet (www.orpha.net) has set up a procedure for the selection, quality evaluation and dissemination of . endobj %���� For this reason, the Ministry feels that it needs to be closer to these people in helping them to enhance their quality of life. Orphanet Journal of Rare Diseases' journal/conference profile on Publons, with 1529 reviews by 688 reviewers - working with reviewers, publishers, institutions, and funding agencies to turn peer review into a measurable research output. 2021-09-12, WHO�s International Classification of Disease, Abnormal origin of right or left pulmonary artery from the aorta, Absence deformity of leg-cataract syndrome, Absence of dermatoglyphics-congenital milia syndrome, Absence of fingerprints-congenital milia syndrome, Absence of pulmonary valve-Fallot tetralogy-absence of ductus arteriosus syndrome, Absent eyebrows and eyelashes-intellectual disability syndrome, Absent patellae-scrotal hypoplasia-renal anomalies-facial dysmorphism-intellectual disability syndrome, Absent radius-anogenital anomalies syndrome, Absent thumb-short stature-immunodeficiency syndrome, Absent tibia-polydactyly-arachnoid cyst syndrome, Acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome, Accelerated skeletal maturation-facial dysmorphism-failure to thrive syndrome, ACE inhibitor-related acquired angioedema, ACER3-related early childhood-onset progressive leukodystrophy, Acetazolamide-responsive congenital myotonia, Achalasia-addisonianism-alacrima syndrome, Achondroplasia-severe combined immunodeficiency syndrome, Achondroplasia-Swiss type agammaglobulinemia syndrome, Acquired aneurysmal subarachnoid hemorrhage, Acquired angioedema with C1Inh deficiency, Acquired angioedema with normal C1 inhibitor, Acquired angioneurotic edema with C1Inh deficiency, Acquired angioneurotic edema with C1 inhibitor deficiency, Acquired chronic primary adrenal insufficiency, Acquired cystic disease-associated renal cell carcinoma, Acquired dermis elastic tissue disorder with decreased elastic tissue, Acquired dermis elastic tissue disorder with increased elastic tissue, Acquired Fanconi syndrome secondary to monoclonal gammopathy, Acquired Gronblad-Strandberg-Touraine syndrome, Acquired hemophagocytic lymphohistiocytosis, Acquired hemophagocytic lymphohistiocytosis associated with malignant disease, Acquired monoclonal Ig light chain-associated Fanconi syndrome, Acquired monoclonal immunoglobulin light chain-associated Fanconi syndrome, Acquired non histamine-induced angioedema, Acquired thrombotic thrombocytopenic purpura, Acral dysostosis with facial and genital abnormalities, Acrodermatitis enteropathica, zinc deficiency type, Acro-dermato-ungual-lacrimal-tooth syndrome, Acrodysostosis with multiple hormone resistance, Acrofacial dysostosis, Genee-Wiedemann type, Acrofacial dysostosis, Kennedy-Teebi type, Acromesomelic dysplasia, Hunter-Thompson type, Acroosteolysis-keloid-like lesions-premature aging syndrome, Acroosteolysis with osteoporosis and changes in skull and mandible, Acrorenal defect-ectodermal dysplasia-diabetes syndrome, ACTH-independent Cushing syndrome due to rare cortisol-producing adrenal tumor, Activation-induced cytidine deaminase deficiency, Acute and subacute inflammatory demyelinating polyneuropathy, Acute and subacute inflammatory demyelinating polyradiculoneuropathy, Acute disseminated encephalomyelitis with anti-MOG antibodies, Acute disseminated encephalomyelitis with anti-myelin oligodendrocyte glycoprotein antibodies, Acute disseminated encephalomyelitis without anti-MOG antibodies, Acute disseminated encephalomyelitis without anti-myelin oligodendrocyte glycoprotein antibodies, Acute encephalitis with refractory repetitive partial seizures, Acute encephalopathy with biphasic seizures and late reduced diffusion, Acute encephalopathy with inflammation-mediated status epilepticus, Acute generalized exanthematous pustulosis, Acute idiopathic demyelinating polyneuropathy, Acute infantile encephalopathy predominantly affecting the frontal lobes, Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome, Acute infantile liver failure due to synthesis defect of mitochondrial DNA-encoded proteins, Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, Acute infantile liver failure-multisystemic involvement syndrome, Acute inflammatory demyelinating polyradiculoneuropathy, Acute megakaryoblastic leukemia in Down syndrome, Acute megakaryoblastic leukemia without Down syndrome, Acute motor and sensory axonal neuropathy, Acute motor-sensory axonal Guillain-Barr� syndrome, Acute multiple sclerosis, Marburg variant, Acute myeloblastic leukemia with maturation, Acute myeloblastic leukemia without maturation, Acute myeloid leukaemia with myelodysplasia-related features, Acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent, Acute myeloid leukemia and myelodysplastic syndromes related to radiation, Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor, Acute myeloid leukemia, minimal differentiation, FAB M0, Acute myeloid leukemia with 11q23 abnormalities, Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22), Acute myeloid leukemia with CEBPA somatic mutations, Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2), Acute myeloid leukemia with minimal differentiation, Acute myeloid leukemia with multilineage dysplasia, Acute myeloid leukemia with NPM1 somatic mutations, Acute myeloid leukemia with recurrent genetic anomaly, Acute myeloid leukemia with t(15;17)(q22;q12);(PML/RARalpha) and variants, Acute myeloid leukemia with t(6;9)(p23;q34), Acute myeloid leukemia with t(8;16)(p11;p13) translocation, Acute myeloid leukemia with t(8;21)(q22;q22) translocation, Acute myeloid leukemia with t(9;11)(p22;q23), Acute myeloid leukemia with t(9;22)(q34.1;q11.2), Acute necrotizing encephalopathy of childhood, Acute non-herpetic encephalitis with severe refractory status epilepticus, Acute panautonomic Guillain-Barr� syndrome, Acute poisoning by drugs with membrane-stabilizing effect, Acute pure sensory Guillain-Barr� syndrome, Acute sensorineural hearing loss by acute acoustic trauma or sudden deafness or surgery induced acoustic trauma, Acute sensory ataxic Guillain-Barr� syndrome, Acute transverse myelitis with anti-MOG antibodies, Acute transverse myelitis with anti-myelin oligodendrocyte glycoprotein antibodies, Acute tubulointerstitial nephritis and uveitis syndrome, Adducted thumbs-arthrogryposis syndrome, Christian type, Adenine phosphoribosyltransferase deficiency, Adenocarcinoma of the gallbladder and EBT, Adenocarcinoma of the gallbladder and extrahepatic biliary tract, Adenocarcinoma of the liver and intrahepatic biliary tract, Adenoid basal carcinoma of the cervix uteri, Adenoid cystic carcinoma of the cervix uteri, Adenosine monophosphate deaminase deficiency, Adenovirus infection in immunocompromised patients, Adenylosuccinate synthetase-like 1-related distal myopathy, ADNP-related syndromic intellectual disability-autism spectrum disorder, Adrenal insufficiency-achalasia-alacrima syndrome, Adrenocortical carcinoma with pure aldosterone hypersecretion, Adrenocorticotropic hormone-dependent Cushing syndrome, Adrenocorticotropic hormone-independent Cushing syndrome, Adrenocorticotropic hormone secretion syndrome, Adult acute respiratory distress syndrome, Adult familial nephronophthisis-spastic quadriparesia syndrome, Adult-onset Alpha-N-acetylgalactosaminidase deficiency, Adult-onset autosomal dominant demyelinating leukodystrophy, Adult-onset autosomal dominant leukodystrophy, Adult-onset autosomal recessive cerebellar ataxia, Adult-onset autosomal recessive sideroblastic anemia, Adult-onset cervical dystonia, DYT23 type, Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy, Adult-onset CPEO with mitochondrial myopathy, Adult-onset distal myopathy due to VCP mutation, Adult-onset foveomacular dystrophy with choroidal neovascularization, Adult-onset foveomacular vitelliform dystrophy, Adult-onset immunodeficiency with acquired anti-interferon-gamma autoantibodies, Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies, Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia, Adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency, Adult-onset multiple mtDNA deletion syndrome due to DGUOK deficiency, Adult-onset vitelliform macular dystrophy, AFG3L2-related spastic ataxia-myoclonic epilepsy-neuropathy syndrome, Agammaglobulinemia-microcephaly-craniosynostosis-severe dermatitis syndrome, Agenesis of corpus callosum with chorioretinal abnormality, Aggressive primary cutaneous B-cell lymphoma, Aggressive primary cutaneous T-cell lymphoma, Agnathia-holoprosencephaly-situs inversus syndrome, Agramatic variant of primary progressive aphasia, AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome, aHUS with neutralizing autoantibodies against factor H, AICAR transformylase/IMP cyclohydrolase deficiency, AKT2-related familial partial lipodystrophy, Alacrimia-choreoathetosis-liver dysfunction syndrome, Alagille syndrome due to 20p12 microdeletion, Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a NOTCH2 point mutation, Alagille-Watson syndrome due to a JAG1 point mutation, Alagille-Watson syndrome due to a NOTCH2 point mutation, Alagille-Watson syndrome due to monosomy 20p12, Alar cartilages hypoplasia-coloboma-telecanthus syndrome, Albright hereditary osteodystrophy-like syndrome, Albright hereditary osteodystrophy-PHP syndrome Ia, Albright hereditary osteodystrophy-PPHP syndrome, Albright hereditary osteodystrophy type 3, Alcohol-related neurodevelopmental disorder, ALK-negative anaplastic large cell lymphoma, ALK-positive anaplastic large cell lymphoma, Alopecia-anosmia-conductive hearing loss-hypogonadism syndrome, Alopecia-anosmia-deafness-hypogonadism syndrome, Alopecia-contractures-dwarfism-intellectual disability syndrome, Alopecia-epilepsy-intellectual disability syndrome, Moynahan type, Alopecia-epilepsy-pyorrhea-intellectual disability syndrome, Alopecia-hearing loss-hypogonadism syndrome, Alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome, Alopecia-intellectual disability syndrome, Alopecia-progressive neurological defect-endocrinopathy syndrome, Alopecia-sensorineural deafness-hypogonadism syndrome, Alopecia-sensorineural hearing loss-hypogonadism syndrome, Alpers progressive sclerosing poliodystrophy, Alpha-1,4-glucosidase acid deficiency, infantile onset, Alpha-1,4-glucosidase acid deficiency, late-onset, Alpha-B crystallin-related late-onset distal myopathy, Alpha-B crystallin-related late-onset myopathy, Alpha-dystroglycan-related limb-girdle muscular dystrophy R16, Alpha-ketoglutarate dehydrogenase deficiency, Alpha-methyl-acetoacetyl-CoA thiolase deficiency, Alpha-methyl-acyl-CoA racemase deficiency, Alpha-N-acetylgalactosaminidase deficiency, Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency type 2, Alpha-N-acetylgalactosaminidase deficiency type 3, Alpha-sarcoglycan-related limb-girdle muscular dystrophy R3, Alpha thalassemia-intellectual disability syndrome, deletion type, Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16, Alpha-thalassemia-myelodysplastic syndrome, Alpha-thalassemia-X-linked intellectual disability syndrome, Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome, Alveolar capillary dysplasia with misalignment of pulmonary veins, Alveolar capillary dysplasia with misalignment of pulmonary vessels, Ambiguous genitalia-disordered steroidogenesis Antley-Bixler syndrome, Amelogenesis imperfecta-nephrocalcinosis syndrome, Ameloonychohypohidrotic ectodermal dysplasia, Amino acid or protein metabolism disease with epilepsy, Aminopterin syndrome-like sine aminopterin, AML and myelodysplastic syndromes related to alkylating agent, AML and myelodysplastic syndromes related to radiation, AML and myelodysplastic syndromes related to topoisomerase type 2 inhibitor, AML with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22), AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2), AML with t(15;17)(q22;q12);(PML/RARalpha) and variants, Angelman syndrome due to a point mutation, Angelman syndrome due to imprinting defect in 15q11-q13, Angelman syndrome due to maternal 15q11q13 deletion, Angelman syndrome due to maternal monosomy 15q11q13, Angelman syndrome due to paternal uniparental disomy of chromosome 15, Angel-shaped phalango-epiphyseal dysplasia, Angiocentric cutaneous T-cell lymphoma of childhood, Angioendotheliomatosis proliferans systemisata, Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome, Anhidrotic ectodermal dysplasia with immunodeficiency, Aniridia-cerebellar ataxia-intellectual disability syndrome, Aniridia-intellectual disability syndrome, Aniridia-ptosis-intellectual disability-familial obesity syndrome, Aniridia-renal agenesis-psychomotor retardation syndrome, ANK3-related intellectual disability-sleep disturbance syndrome, Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome, Ankyloblepharon filiforme adnatum-cleft palate syndrome, Ankyloblepharon filiforme adnatum-imperforate anus syndrome, Ankylosing vertebral hyperostosis with tylosis, Anoctamin-5-related limb-girdle muscular dystrophy R12, Anomalous aortic origin of coronary artery, Anomalous aortic origin of the left coronary artery, Anomalous aortic origin of the right coronary artery, Anomalous origin of coronary artery from the pulmonary artery, Anomaly of puberty or/and menstrual cycle, Anomaly of puberty or/and menstrual cycle of genetic origin, Anomaly of the mitral subvalvular apparatus, Anomaly of the tricuspid subvalvular apparatus, Anonychia-onychodystrophy with hypoplasia or absence of distal phalanges syndrome, Anophthalmia-megalocornea-cardiopathy-skeletal anomalies syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia-pulmonary hypoplasia syndrome, Antenatal multiminicore disease with arthrogryposis multiplex congenita, Anterior cutaneous nerve entrapment syndrome, Anterior limiting membrane dystrophy type 1, Anterior limiting membrane dystrophy type 2, Anterior limiting membrane dystrophy type I, Anterior limiting membrane dystrophy type II, Anterior maxillary protrusion-strabismus-intellectual disability syndrome, Anterior segment developmental abnormality with extraocular manifestations, Anterior segment developmental anomaly of genetic origin, Anterior segment developmental anomaly without extraocular manifestations, Anti-glomerular basement membrane disease, Antineutrophil cytoplasmic antibody-associated vasculitis, Anti-neutrophil cytoplasmic antibody-associated vasculitis, Antineutrophil cytoplasmic antibody-negative pauci-immune glomerulonephritis, Antley-Bixler syndrome with genital anomaly and disorder of steroidogenesis, Antley-Bixler syndrome without genital anomaly or disorder of steroidogenesis, Aortic aneurysm syndrome due to TGF-beta receptors anomalies, Aortic arch anomaly-facial dysmorphism-intellectual disability syndrome, APC-related attenuated familial adenomatous polyposis, APC-related attenuated familial polyposis coli, Aphalangy-hemivertebrae-urogenital-intestinal dysgenesis syndrome, Aphalangy-syndactyly-microcephaly syndrome, Aphonia-deafness-retinal dystrophy-bifid halluces-intellectual disability syndrome, Aphonia-deafness-retinal dystrophy-duplicated halluces-intellectual disability syndrome, Aphonia-hearing loss-retinal dystrophy-duplicated halluces-intellectual disability syndrome, Aplasia cutis congenita-epibulbar dermoids syndrome, Aplasia cutis congenita-intestinal lymphangiectasia syndrome, Aplasia cutis congenita-nevus sebaceus syndrome, Aplasia of tibia with split-hand/split-foot deformity, Apolipoprotein A-I binding protein deficiency, Apple-peel intestinal atresia-ocular anomalies-microcephaly syndrome, Arachnodactyly-abnormal ossification-intellectual disability syndrome, Arachnodactyly-intellectual disability-dysmorphism syndrome, Argininosuccinic acid synthase deficiency, Argininosuccinic acid synthetase deficiency, Aromatic L-amino acid decarboxylase deficiency, Arrhinia-choanal atresia-microphthalmia syndrome, Arrhythmogenic right ventricular cardiomyopathy, Arrhythmogenic right ventricular dysplasia, Arterial dissection-lentiginosis syndrome, Arterial thoracic outlet compression syndrome, Arteriohepatic dysplasia due to a JAG1 point mutation, Arteriohepatic dysplasia due to a NOTCH2 point mutation, Arteriohepatic dysplasia due to monosomy 20p12, Arthrogryposis-anterior horn cell disease syndrome, Arthrogryposis-ectodermal dysplasia syndrome, Arthrogryposis-hyperkeratosis syndrome, lethal form, Arthrogryposis-like hand anomaly-sensorineural deafness syndrome, Arthrogryposis-like hand anomaly-sensorineural hearing loss syndrome, Arthrogryposis multiplex congenita-pulmonary hypoplasia syndrome, Arthrogryposis multiplex congenita-whistling face syndrome, Arthrogryposis-oculomotor limitation-electroretinal anomalies syndrome, Arthrogryposis-renal dysfunction-cholestasis syndrome, ARX-related encephalopathy-brain malformation spectrum, Arylsulfatase A deficiency, juvenile form, Arylsulfatase A deficiency, late infantile form, Arylsulfatase B deficiency, rapidly progressing, Arylsulfatase B deficiency, slowly progressing, Aseptic necrosis of the capital femoral epiphysis, Asphyxiating thoracic dystrophy of the newborn, Ataxia-deafness-intellectual disability syndrome, Ataxia-delayed dentition-hypomyelination syndrome, Ataxia-diabetes-goiter-gonadal insufficiency syndrome, Ataxia-hearing loss-intellectual disability syndrome, Ataxia-hypogonadism-choroidal dystrophy syndrome, Ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndrome, Ataxia-photosensitivity-short stature syndrome, Ataxia-tapetoretinal degeneration syndrome, Ataxia with isolated vitamin E deficiency, Ataxie spinoc�r�belleuse � d�but infantile avec retard psychomoteur, Atherosclerosis-deafness-diabetes-epilepsy-nephropathy syndrome, Atherosclerosis-hearing loss-diabetes-epilepsy-nephropathy syndrome, Athyroidal hypothyroidism-spiky hair-cleft palate syndrome, ATP13A2-related juvenile neuronal ceroid lipofuscinosis, ATP1A1-related autosomal dominant Charcot-Marie-Tooth disease type 2, ATP-binding cassette transporter A1 deficiency, Atrial defect and interauricular communication, Atrial septal defect-atrioventricular conduction defects syndrome, Atrial septal defect, coronary sinus type, Atrial septal defect, ostium secundum type, Atrial tachyarrhythmia with short PR interval, Atrioventricular defect-blepharophimosis-radial and anal defect syndrome, Attenuated familial adenomatous polyposis, Atypical dentin dysplasia due to SMOC2 deficiency, Atypical Fanconi syndrome-neonatal hyperinsulinism syndrome, Atypical Gaucher disease due to saposin C deficiency, Atypical hemolytic uremic syndrome with anti-factor H antibodies, Atypical hemolytic uremic syndrome with complement gene abnormality, Atypical HUS with anti-factor H antibodies, Atypical HUS with complement gene abnormality, Atypical Norrie disease due to del(X)(p11.3), Atypical Norrie disease due to nullisomy Xp11.3, Atypical Norrie disease due to Xp11.3 microdeletion, Atypical pantothenate kinase-associated neurodegeneration, Atypical progressive supranuclear palsy syndrome, Atypical tuberous myxedema of Jadassohn-Dosseker, Auditory neuropathy-optic atrophy syndrome, Aural atresia-multiple congenital anomalies-intellectual disability syndrome, Auricular abnormalities-cleft lip with or without cleft palate-ocular abnormalities syndrome, Autism-epilepsy syndrome due to branched chain ketoacid dehydrogenase kinase deficiency, Autism spectrum disorder due to AUTS2 deficiency, Autism spectrum disorder-epilepsy-arthrogryposis syndrome, Autoantibody-negative autoimmune hepatitis, Autoimmune encephalopathy with parasomnia and obstructive sleep apnea, Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome, Autoimmune hemolytic anemia and autoimmune thrombocytopenia, Autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome, Autoimmune hypoparathyroidism-chronic candidiasis-Addison disease syndrome, Autoimmune interstitial lung disease-arthritis syndrome, Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency, Autoimmune lymphoproliferative syndrome with recurrent viral infections, Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome, Autoimmune pulmonary alveolar proteinosis, Autoimmune thrombotic thrombocytopenic purpura, Autoimmune thyroid disease and/or type 1 diabetes-Addison disease syndrome, Autoinflammation-lipodystrophy-dermatosis syndrome, Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation, Autoinflammatory disease due to interleukin-1 receptor antagonist deficiency, Autoinflammatory syndrome with immune deficiency, Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis, Autoinflammatory syndrome with skin involvement, Autosomal dominant adult-onset proximal SMA, Autosomal dominant adult-onset proximal spinal muscular atrophy, Autosomal dominant anhidrotic ectodermal dysplasia, Autosomal dominant aplasia and myelodysplasia, Autosomal dominant aplastic anemia and myelodysplasia, Autosomal dominant axonal Charcot-Marie-Tooth disease, Autosomal dominant benign distal spinal muscular atrophy, Autosomal dominant beta2-microglobulinic amyloidosis, Autosomal dominant centronuclear myopathy, Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome, Autosomal dominant cerebellar ataxia-hearing loss-narcolepsy syndrome, Autosomal dominant cerebellar ataxia type 1, Autosomal dominant cerebellar ataxia type 2, Autosomal dominant cerebellar ataxia type 3, Autosomal dominant cerebellar ataxia type 4, Autosomal dominant cerebellar ataxia type I, Autosomal dominant cerebellar ataxia type II, Autosomal dominant cerebellar ataxia type III, Autosomal dominant cerebellar ataxia type IV, Autosomal dominant Charcot-Marie-Tooth disease type 2, Autosomal dominant Charcot-Marie-Tooth disease type 2A1, Autosomal dominant Charcot-Marie-Tooth disease type 2A2, Autosomal dominant Charcot-Marie-Tooth disease type 2B, Autosomal dominant Charcot-Marie-Tooth disease type 2C, Autosomal dominant Charcot-Marie-Tooth disease type 2D, Autosomal dominant Charcot-Marie-Tooth disease type 2DD, Autosomal dominant Charcot-Marie-Tooth disease type 2 due to DGAT2 mutation, Autosomal dominant Charcot-Marie-Tooth disease type 2 due to HARS mutation, Autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation, Autosomal dominant Charcot-Marie-Tooth disease type 2 due to MARS mutation, Autosomal dominant Charcot-Marie-Tooth disease type 2 due to MORC2 mutation, Autosomal dominant Charcot-Marie-Tooth disease type 2 due to NAGLU mutation, Autosomal dominant Charcot-Marie-Tooth disease type 2 due to TFG mutation, Autosomal dominant Charcot-Marie-Tooth disease type 2 due to VCP mutation, Autosomal dominant Charcot-Marie-Tooth disease type 2E, Autosomal dominant Charcot-Marie-Tooth disease type 2F, Autosomal dominant Charcot-Marie-Tooth disease type 2G, Autosomal dominant Charcot-Marie-Tooth disease type 2I, Autosomal dominant Charcot-Marie-Tooth disease type 2J, Autosomal dominant Charcot-Marie-Tooth disease type 2K, Autosomal dominant Charcot-Marie-Tooth disease type 2L, Autosomal dominant Charcot-Marie-Tooth disease type 2M, Autosomal dominant Charcot-Marie-Tooth disease type 2N, Autosomal dominant Charcot-Marie-Tooth disease type 2O, Autosomal dominant Charcot-Marie-Tooth disease type 2Q, Autosomal dominant Charcot-Marie-Tooth disease type 2U, Autosomal dominant Charcot-Marie-Tooth disease type 2V, Autosomal dominant Charcot-Marie-Tooth disease type 2W, Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons, Autosomal dominant Charcot-Marie-Tooth disease type 2Y, Autosomal dominant Charcot-Marie-Tooth disease type 2Z, Autosomal dominant childhood-onset proximal spinal muscular atrophy, Autosomal dominant complex spastic paraplegia, Autosomal dominant complicated spastic paraplegia, Autosomal dominant congenital benign spinal muscular atrophy, Autosomal dominant congenital hereditary endothelial dystrophy, Autosomal dominant cortical myoclonus and epilepsy, Autosomal dominant deafness-onychodystrophy syndrome, Autosomal dominant demyelinating Charcot-Marie-Tooth disease, Autosomal dominant diffuse mutilating palmoplantar hyperkeratosis, Autosomal dominant diffuse mutilating palmoplantar keratoderma, Autosomal dominant diffuse palmoplantar keratoderma, Norrbotten type, Autosomal dominant disease associated with focal palmoplantar hyperkeratosis as a major feature, Autosomal dominant disease associated with focal palmoplantar keratoderma as a major feature, Autosomal dominant disease associated with punctate palmoplantar hyperkeratosis as a major feature, Autosomal dominant disease associated with punctate palmoplantar keratoderma as a major feature, Autosomal dominant disease with diffuse palmoplantar hyperkeratosis as a major feature, Autosomal dominant disease with diffuse palmoplantar keratoderma as a major feature, Autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome, Autosomal dominant distal hereditary motor neuropathy, Autosomal dominant distal juvenile spinal muscular atrophy type 1, Autosomal dominant distal renal tubular acidosis, Autosomal dominant distal spinal muscular atrophy, Autosomal dominant dopa-responsive dystonia, Autosomal dominant ectodermal dysplasia-cancer predisposition syndrome, Autosomal dominant Emery-Dreifuss muscular dystrophy, Autosomal dominant epidermolytic ichthyosis, Autosomal dominant epilepsy with auditory features, Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome, Autosomal dominant focal dystonia, DYT25 type, Autosomal dominant focal non-epidermolytic palmoplantar keratoderma with plantar blistering, Autosomal dominant generalized dystrophic epidermolysis bullosa, Autosomal dominant generalized EBS, intermediate form, Autosomal dominant generalized EBS, severe form, Autosomal dominant generalized epidermolysis bullosa simplex, intermediate form, Autosomal dominant generalized epidermolysis bullosa simplex, severe form, Autosomal dominant hearing loss-onychodystrophy syndrome, Autosomal dominant hereditary axonal motor and sensory neuropathy, Autosomal dominant hereditary demyelinating motor and sensory neuropathy, Autosomal dominant hereditary hemochromatosis, Autosomal dominant hereditary motor and sensory neuropathy type 2 with giant axons, Autosomal dominant hereditary sensory and autonomic neuropathy, Autosomal dominant hyperimmunoglobulin E syndrome, Autosomal dominant hyperinsulinemic hypoglycemia due to Kir6.2 deficiency, Autosomal dominant hyperinsulinemic hypoglycemia due to SUR1 deficiency, Autosomal dominant hyperinsulinism due to Kir6.2 deficiency, Autosomal dominant hyperinsulinism due to SUR1 deficiency, Autosomal dominant hypohidrotic ectodermal dysplasia, Autosomal dominant hypophosphatemic rickets, Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Autosomal dominant intermediate Charcot-Marie-Tooth disease, Autosomal dominant intermediate Charcot-Marie-Tooth disease type A, Autosomal dominant intermediate Charcot-Marie-Tooth disease type B, Autosomal dominant intermediate Charcot-Marie-Tooth disease type C, Autosomal dominant intermediate Charcot-Marie-Tooth disease type D, Autosomal dominant intermediate Charcot-Marie-Tooth disease type E, Autosomal dominant intermediate Charcot-Marie-Tooth disease type F, Autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic pain, Autosomal dominant intermediate CMT disease with neuropathic pain, Autosomal dominant isolated diffuse palmoplantar hyperkeratosis, Autosomal dominant isolated diffuse palmoplantar keratoderma, Autosomal dominant isolated neurosensory deafness type DFNA, Autosomal dominant isolated neurosensory hearing loss type DFNA, Autosomal dominant isolated sensorineural deafness type DFNA, Autosomal dominant isolated sensorineural hearing loss type DFNA, Autosomal dominant keratoconus with early-onset anterior polar cataracts, Autosomal dominant late-onset Parkinson disease, Autosomal dominant late-onset retinal degeneration, Autosomal dominant late-onset spinal muscular atrophy, Finkel type, Autosomal dominant lateral temporal lobe epilepsy, Autosomal dominant leukoencephalopathy with neuroaxonal spheroids, Autosomal dominant limb-girdle muscular dystrophy, Autosomal dominant limb-girdle muscular dystrophy type 1A, Autosomal dominant limb-girdle muscular dystrophy type 1D, Autosomal dominant limb-girdle muscular dystrophy type 1F, Autosomal dominant limb-girdle muscular dystrophy type 1G, Autosomal dominant limb-girdle muscular dystrophy type 1H, Autosomal dominant mendelian susceptibility to mycobacterial diseases due to a partial deficiency, Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency, Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency, Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial interferon gamma receptor 1 deficiency, Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial interferon gamma receptor 2 deficiency, Autosomal dominant mitochondrial myopathy with exercise intolerance, Autosomal dominant MSMD due to a partial deficiency, Autosomal dominant MSMD due to partial IFNgammaR1 deficiency, Autosomal dominant MSMD due to partial IFNgammaR2 deficiency, Autosomal dominant MSMD due to partial interferon gamma receptor 1 deficiency, Autosomal dominant MSMD due to partial interferon gamma receptor 2 deficiency, Autosomal dominant multiple pterygium syndrome, Autosomal dominant myopia-midfacial retrusion-sensorineural deafness-rhizomelic dysplasia syndrome, Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome, Autosomal dominant neovascular inflammatory vitreoretinopathy, Autosomal dominant nocturnal frontal lobe epilepsy, Autosomal dominant non-syndromic intellectual disability, Autosomal dominant non-syndromic neurosensory deafness type DFNA, Autosomal dominant non-syndromic neurosensory hearing loss type DFNA, Autosomal dominant non-syndromic sensorineural deafness type DFNA, Autosomal dominant non-syndromic sensorineural hearing loss type DFNA, Autosomal dominant optic atrophy and cataract, Autosomal dominant optic atrophy and peripheral neuropathy, Autosomal dominant optic atrophy, classic form, Autosomal dominant optic atrophy, Kjer type, Autosomal dominant optic atrophy plus syndrome, Autosomal dominant osteosclerosis, Stanescu type, Autosomal dominant osteosclerosis, Worth type, Autosomal dominant otospondylomegaepiphyseal dysplasia, Autosomal dominant palmoplantar hyperkeratosis and congenital alopecia, Autosomal dominant palmoplantar keratoderma and congenital alopecia, Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis, Autosomal dominant polycystic liver disease, Autosomal dominant popliteal pterygium syndrome, Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome, Autosomal dominant primary hypomagnesemia with hypocalciuria, Autosomal dominant progressive external ophthalmoplegia, Autosomal dominant progressive nephropathy with hypertension, Autosomal dominant proximal renal tubular acidosis, Autosomal dominant proximal spinal muscular atrophy, Autosomal dominant pseudohypoaldosteronism type 1, Autosomal dominant pure spastic paraplegia, Autosomal dominant rhegmatogenous retinal detachment, Autosomal dominant secondary erythrocytosis, Autosomal dominant secondary polycythemia, Autosomal dominant severe congenital neutropenia, Autosomal dominant sleep-related hypermotor epilepsy, Autosomal dominant slowed nerve conduction velocity, Autosomal dominant spastic paraplegia type 10, Autosomal dominant spastic paraplegia type 12, Autosomal dominant spastic paraplegia type 13, Autosomal dominant spastic paraplegia type 17, Autosomal dominant spastic paraplegia type 19, Autosomal dominant spastic paraplegia type 29, Autosomal dominant spastic paraplegia type 3, Autosomal dominant spastic paraplegia type 31, Autosomal dominant spastic paraplegia type 36, Autosomal dominant spastic paraplegia type 37, Autosomal dominant spastic paraplegia type 38, Autosomal dominant spastic paraplegia type 4, Autosomal dominant spastic paraplegia type 41, Autosomal dominant spastic paraplegia type 42, Autosomal dominant spastic paraplegia type 6, Autosomal dominant spastic paraplegia type 73, Autosomal dominant spastic paraplegia type 8, Autosomal dominant spastic paraplegia type 9A, Autosomal dominant spastic paraplegia type 9B, Autosomal dominant spinocerebellar ataxia, Autosomal dominant spondylocostal dysostosis, Autosomal dominant spondylocostal dysplasia, Autosomal dominant striatal neurodegeneration, Autosomal dominant thrombocytopenia with platelet secretion defect, Autosomal dominant tubulointerstitial kidney disease, Autosomal dominant uncomplicated spastic paraplegia, Autosomal dominant vitreoretinochoroidopathy, Autosomal ichthyosis syndrome with fatal disease course, Autosomal ichthyosis syndrome with other associated signs, Autosomal ichthyosis syndrome with prominent hair abnormalities, Autosomal ichthyosis syndrome with prominent neurologic signs, Autosomal recessive anhidrotic ectodermal dysplasia, Autosomal recessive anterior segment dysgenesis, Autosomal recessive ataxia due to coenzyme Q10 deficiency, Autosomal recessive ataxia due to PEX10 deficiency, Autosomal recessive ataxia due to ubiquinone deficiency, Autosomal recessive axonal Charcot-Marie-Tooth disease due to copper metabolism defect, Autosomal recessive axonal Charcot-Marie-Tooth disease type 2, Autosomal recessive axonal Charcot-Marie-Tooth disease type 2B2, Autosomal recessive axonal Charcot-Marie-Tooth disease type 2K, Autosomal recessive axonal Charcot-Marie-Tooth disease type 2T, Autosomal recessive axonal Charcot-Marie-Tooth disease with acrodystrophy, Autosomal recessive axonal CMT due to copper metabolism defect, Autosomal recessive axonal hereditary motor and sensory neuropathy, Autosomal recessive axonal neuropathy with neuromyotonia, Autosomal recessive centronuclear myopathy, Autosomal recessive cerebellar ataxia due to a DNA repair defect, Autosomal recessive cerebellar ataxia due to CWF19L1 deficiency, Autosomal recessive cerebellar ataxia due to GBA2 deficiency, Autosomal recessive cerebellar ataxia due to STUB1 deficiency, Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome, Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to RUBCN deficiency, Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency, Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to WWOX deficiency, Autosomal recessive cerebellar ataxia-movement disorder syndrome, Autosomal recessive cerebellar ataxia-psychomotor delay syndrome, Autosomal recessive cerebellar ataxia-pyramidal signs-nystagmus-oculomotor apraxia syndrome, Autosomal recessive cerebellar ataxia type 1, Autosomal recessive cerebellar ataxia type 2, Autosomal recessive cerebellar ataxia with late-onset spasticity, Autosomal recessive cerebelloparenchymal disorder type 3, Autosomal recessive Charcot-Marie-Tooth disease, Ouvrier type, Autosomal recessive Charcot-Marie-Tooth disease type 2B1, Autosomal recessive Charcot-Marie-Tooth disease type 2B5, Autosomal recessive Charcot-Marie-Tooth disease type 2 due to SPG11 mutation, Autosomal recessive Charcot-Marie-Tooth disease type 2 with neuromyotonia, Autosomal recessive Charcot-Marie-Tooth disease type 2X, Autosomal recessive Charcot-Marie-Tooth disease with hoarseness, Autosomal recessive Charcot-Marie-Tooth type 2 with acrodystrophy, Autosomal recessive childhood-onset dystonia, DYT29 type, Autosomal recessive chorioretinopathy-microcephaly-intellectual disability syndrome, Autosomal recessive chorioretinopathy-microcephaly syndrome, Autosomal recessive complex spastic paraplegia, Autosomal recessive complex spastic paraplegia due to Kennedy pathway dysfunction, Autosomal recessive complex SPG due to Kennedy pathway dysfunction, Autosomal recessive complicated spastic paraplegia, Autosomal recessive congenital cerebellar ataxia, Autosomal recessive congenital cerebellar ataxia due to GRID2 deficiency, Autosomal recessive congenital cerebellar ataxia due to ionotropic glutamate receptor delta-2 subunit deficiency, Autosomal recessive congenital cerebellar ataxia due to metabotropic glutamate receptor 1 deficiency, Autosomal recessive congenital cerebellar ataxia due to MGLUR1 deficiency, Autosomal recessive congenital hereditary endothelial dystrophy, Autosomal recessive congenital hypomyelinating neuropathy, Autosomal recessive congenital ichthyosis, Autosomal recessive cutis laxa, pulmonary emphysema type, Autosomal recessive cutis laxa type 2, classic type, Autosomal recessive cutis laxa type 2, Debr� type, Autosomal recessive cutis laxa type 2, progeroid type, Autosomal recessive cutis laxa with severe systemic involvement, Autosomal recessive deafness-onychodystrophy syndrome, Autosomal recessive degenerative and progressive cerebellar ataxia, Autosomal recessive demyelinating Charcot-Marie-Tooth, Autosomal recessive disease associated with punctate palmoplantar hyperkeratosis as a major feature, Autosomal recessive disease associated with punctate palmoplantar keratoderma as a major feature, Autosomal recessive disease with diffuse palmoplantar hyperkeratosis as a major feature, Autosomal recessive disease with diffuse palmoplantar keratoderma as a major feature, Autosomal recessive disease with focal palmoplantar hyperkeratosis as a major feature, Autosomal recessive disease with focal palmoplantar keratoderma as a major feature, Autosomal recessive distal hereditary motor neuropathy, Autosomal recessive distal osteolysis syndrome, Autosomal recessive distal renal tubular acidosis, Autosomal recessive distal spinal muscular atrophy, Autosomal recessive distal spinal muscular atrophy type 1, Autosomal recessive distal spinal muscular atrophy type 2, Autosomal recessive distal spinal muscular atrophy type 3, Autosomal recessive distal spinal muscular atrophy type 4, Autosomal recessive distal spinal muscular atrophy type 5, Autosomal recessive dopa-responsive dystonia, Autosomal recessive dystrophic epidermolysis bullosa generalisata gravis, Autosomal recessive dystrophic epidermolysis bullosa generalisata mitis, Autosomal recessive dystrophic epidermolysis bullosa, Hallopeau-Siemens type, Autosomal recessive dystrophic epidermolysis bullosa, non-Hallopeau-Siemens type, Autosomal recessive Emery-Dreifuss muscular dystrophy, Autosomal recessive epidermolytic ichthyosis, Autosomal recessive exfoliative ichthyosis, Autosomal recessive faciodigitogenital syndrome, Autosomal recessive frontotemporal pachygyria, Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form, Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form, Autosomal recessive generalized epidermolysis bullosa simplex, Autosomal recessive hearing loss-onychodystrophy syndrome, Autosomal recessive hereditary demyelinating motor and sensory neuropathy, Autosomal recessive hereditary sensory and autonomic neuropathy, Autosomal recessive hyper-IgE syndrome due to TYK2 deficiency, Autosomal recessive hyperinsulinemic hypoglycemia due to Kir6.2 deficiency, Autosomal recessive hyperinsulinemic hypoglycemia due to SUR1 deficiency, Autosomal recessive hyperinsulinism due to Kir6.2 deficiency, Autosomal recessive hyperinsulinism due to SUR1 deficiency, Autosomal recessive hypohidrotic ectodermal dysplasia, Autosomal recessive hypomyelinating leukodystrophy-progressive spastic ataxia, Autosomal recessive hypophosphatemic rickets, Autosomal recessive infantile hypercalcemia, Autosomal recessive infantile nephronophthisis, Autosomal recessive intellectual disability due to TRAPPC9 deficiency, Autosomal recessive intermediate Charcot-Marie-Tooth disease, Autosomal recessive intermediate Charcot-Marie-Tooth disease type A, Autosomal recessive intermediate Charcot-Marie-Tooth disease type B, Autosomal recessive intermediate Charcot-Marie-Tooth disease type C, Autosomal recessive intermediate Charcot-Marie-Tooth disease type D, Autosomal recessive intermediate osteopetrosis, Autosomal recessive isolated diffuse palmoplantar hyperkeratosis, Autosomal recessive isolated diffuse palmoplantar keratoderma, Autosomal recessive isolated neurosensory deafness type DFNB, Autosomal recessive isolated neurosensory hearing loss type DFNB, Autosomal recessive isolated optic atrophy, Autosomal recessive isolated sensorineural deafness type DFNB, Autosomal recessive isolated sensorineural hearing loss type DFNB, Autosomal recessive Kenny-Caffey syndrome, Autosomal recessive lethal chondrodysplasia, round femoral inferior epiphysis type, Autosomal recessive lethal multiple pterygium syndrome, Autosomal recessive lethal neonatal axonal sensorimotor polyneuropathy, Autosomal recessive leukoencephalopathy-ischemic stroke-retinitis pigmentosa syndrome, Autosomal recessive limb-girdle muscular dystrophy, Autosomal recessive limb-girdle muscular dystrophy-cardiac arrhythmia syndrome, Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2B, Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2E, Autosomal recessive limb-girdle muscular dystrophy type 2F, Autosomal recessive limb-girdle muscular dystrophy type 2G, Autosomal recessive limb-girdle muscular dystrophy type 2H, Autosomal recessive limb-girdle muscular dystrophy type 2I, Autosomal recessive limb-girdle muscular dystrophy type 2J, Autosomal recessive limb-girdle muscular dystrophy type 2K, Autosomal recessive limb-girdle muscular dystrophy type 2L, Autosomal recessive limb-girdle muscular dystrophy type 2M, Autosomal recessive limb-girdle muscular dystrophy type 2N, Autosomal recessive limb-girdle muscular dystrophy type 2O, Autosomal recessive limb-girdle muscular dystrophy type 2P, Autosomal recessive limb-girdle muscular dystrophy type 2Q, Autosomal recessive limb-girdle muscular dystrophy type 2S, Autosomal recessive limb-girdle muscular dystrophy type 2T, Autosomal recessive limb-girdle muscular dystrophy type 2U, Autosomal recessive limb-girdle muscular dystrophy type 2W, Autosomal recessive limb-girdle muscular dystrophy type 2Y, Autosomal recessive limb-girdle muscular dystrophy type 2Z, Autosomal recessive lower motor neuron disease with childhood onset, Autosomal recessive lymphoproliferative disease due to CD27 deficiency, Autosomal recessive lymphoproliferative disease due to ITK deficiency, Autosomal recessive malignant osteopetrosis, Autosomal recessive mendelian susceptibility to mycobacterial diseases due to a complete deficiency, Autosomal recessive mendelian susceptibility to mycobacterial diseases due to a partial deficiency, Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency, Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency, Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency, Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial interferon gamma receptor 1 deficiency, Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial interferon gamma receptor 2 deficiency, Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial JAK1 deficiency, Autosomal recessive metabolic cerebellar ataxia, Autosomal recessive metaphyseal chondrodysplasia, Autosomal recessive MSMD due to a complete deficiency, Autosomal recessive MSMD due to a partial deficiency, Autosomal recessive MSMD due to complete RORgamma receptor defiency, Autosomal recessive MSMD due to partial IFNgammaR1 deficiency, Autosomal recessive MSMD due to partial IFNgammaR2 deficiency, Autosomal recessive MSMD due to partial interferon gamma receptor 1 deficiency, Autosomal recessive MSMD due to partial interferon gamma receptor 2 deficiency, Autosomal recessive MSMD due to partial JAK1 deficiency, Autosomal recessive multiple epiphyseal dysplasia, Autosomal recessive multiple pterygium syndrome, Autosomal recessive muscular dystrophy due to LAP1B deficiency, Autosomal recessive muscular dystrophy due to Torsin-1A-interacting protein 1 deficiency, Autosomal recessive myogenic arthrogryposis multiplex congenita, Autosomal recessive non-lethal multiple pterygium syndrome, Autosomal recessive non-syndromic intellectual disability, Autosomal recessive non-syndromic neurosensory deafness type DFNB, Autosomal recessive non-syndromic neurosensory hearing loss type DFNB, Autosomal recessive non-syndromic optic atrophy, Autosomal recessive non-syndromic sensorineural deafness type DFNB, Autosomal recessive non-syndromic sensorineural hearing loss type DFNB, Autosomal recessive optic atrophy, OPA7 type, Autosomal recessive optic atrophy plus syndrome, Autosomal recessive osteoclast-poor osteopetrosis with hypogammaglobulinemia, Autosomal recessive palmoplantar hyperkeratosis and congenital alopecia, Autosomal recessive palmoplantar keratoderma and congenital alopecia, Autosomal recessive polycystic kidney disease, Autosomal recessive popliteal pterygium syndrome, Autosomal recessive posterior column ataxia and retinitis pigmentosa, Autosomal recessive primary immunodeficiency due to RORC mutation, Autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity, Autosomal recessive primary immunodeficiency with defective spontaneous NK cell cytotoxicity, Autosomal recessive progressive external ophthalmoplegia, Autosomal recessive proximal renal tubular acidosis, Autosomal recessive pseudohypoaldosteronism type 1, Autosomal recessive pure spastic paraplegia, Autosomal recessive secondary erythrocytosis, non-Chuvash type, Autosomal recessive secondary erythrocytosis not associated with VHL gene, Autosomal recessive secondary polycythemia, non-Chuvash type, Autosomal recessive secondary polycythemia not associated with VHL gene, Autosomal recessive sensory radicular neuropathy, Autosomal recessive sepiapterin reductase-deficient DRD, Autosomal recessive severe congenital neutropenia, Autosomal recessive severe congenital neutropenia due to CSF3R deficiency, Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, Autosomal recessive severe congenital neutropenia due to JAGN1 deficiency, Autosomal recessive spastic ataxia of Charlevoix-Saguenay, Autosomal recessive spastic ataxia-optic atrophy-dysarthria syndrome, Autosomal recessive spastic ataxia type 3, Autosomal recessive spastic ataxia type 4, Autosomal recessive spastic ataxia type 5, Autosomal recessive spastic ataxia type 6, Autosomal recessive spastic ataxia with leukoencephalopathy, Autosomal recessive spastic paraplegia-disc herniation syndrome, Autosomal recessive spastic paraplegia type 11, Autosomal recessive spastic paraplegia type 14, Autosomal recessive spastic paraplegia type 15, Autosomal recessive spastic paraplegia type 18, Autosomal recessive spastic paraplegia type 20, Autosomal recessive spastic paraplegia type 21, Autosomal recessive spastic paraplegia type 23, Autosomal recessive spastic paraplegia type 24, Autosomal recessive spastic paraplegia type 25, Autosomal recessive spastic paraplegia type 26, Autosomal recessive spastic paraplegia type 27, Autosomal recessive spastic paraplegia type 28, Autosomal recessive spastic paraplegia type 32, Autosomal recessive spastic paraplegia type 35, Autosomal recessive spastic paraplegia type 39, Autosomal recessive spastic paraplegia type 43, Autosomal recessive spastic paraplegia type 44, Autosomal recessive spastic paraplegia type 45, Autosomal recessive spastic paraplegia type 46, Autosomal recessive spastic paraplegia type 48, Autosomal recessive spastic paraplegia type 49, Autosomal recessive spastic paraplegia type 53, Autosomal recessive spastic paraplegia type 54, Autosomal recessive spastic paraplegia type 55, Autosomal recessive spastic paraplegia type 56, Autosomal recessive spastic paraplegia type 57, Autosomal recessive spastic paraplegia type 59, Autosomal recessive spastic paraplegia type 5A, Autosomal recessive spastic paraplegia type 60, Autosomal recessive spastic paraplegia type 61, Autosomal recessive spastic paraplegia type 62, Autosomal recessive spastic paraplegia type 63, Autosomal recessive spastic paraplegia type 64, Autosomal recessive spastic paraplegia type 65, Autosomal recessive spastic paraplegia type 66, Autosomal recessive spastic paraplegia type 67, Autosomal recessive spastic paraplegia type 69, Autosomal recessive spastic paraplegia type 70, Autosomal recessive spastic paraplegia type 71, Autosomal recessive spastic paraplegia type 74, Autosomal recessive spastic paraplegia type 75, Autosomal recessive spastic paraplegia type 76, Autosomal recessive spastic paraplegia type 77, Autosomal recessive spastic paraplegia type 78, Autosomal recessive spastic paraplegia type 9B, Autosomal recessive spinal muscular atrophy with respiratory distress, Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome, Autosomal recessive spinocerebellar ataxia-blindness-hearing loss syndrome, Autosomal recessive spinocerebellar ataxia type 10, Autosomal recessive spinocerebellar ataxia type 11, Autosomal recessive spinocerebellar ataxia type 12, Autosomal recessive spinocerebellar ataxia type 13, Autosomal recessive spinocerebellar ataxia type 14, Autosomal recessive spinocerebellar ataxia type 15, Autosomal recessive spinocerebellar ataxia type 2, Autosomal recessive spinocerebellar ataxia type 20, Autosomal recessive spinocerebellar ataxia type 21, Autosomal recessive spinocerebellar ataxia type 3, Autosomal recessive spinocerebellar ataxia type 6, Autosomal recessive spinocerebellar ataxia type 7, Autosomal recessive spinocerebellar ataxia type 9, Autosomal recessive spondylocostal dysostosis, Autosomal recessive spondylometaphyseal dysplasia, M�garban� type, Autosomal recessive syndromic cerebellar ataxia, Autosomal recessive thrombophilia due to congenital protein C deficiency, Autosomal recessive thrombophilia due to congenital protein S deficiency, Autosomal recessive thrombophilia due to PC deficiency, Autosomal recessive uncomplicated spastic paraplegia, Autosomal semi-dominant severe lipodystrophic laminopathy, Autosomal thrombocytopenia with normal platelets, Avascular necrosis of the metatarsal bone, AXIN2-related attenuated familial adenomatous polyposis, AXIN2-related attenuated familial polyposis coli, Axonal Charcot-Marie-Tooth disease with pyramidal involvement, Axonal hereditary motor and sensory neuropathy, Axonal neuropathy-optic atrophy-cognitive deficit syndrome, Axonal polyneuropathy associated with IgG/IgM/IgA monoclonal gammopathy, Azoospermia-sinopulmonary infections syndrome, Azygos continuation of the inferior caval vein, Azygos continuation of the inferior vena cava. Insideon a regular basis, Orphanet publishes an overview of rare diseases in Europe which is monthly! These diseases, the journal may consider articles on clinical trial outcome reports either... Rarity of these diseases, known as orphan products/drugs Page 1245Orphanet Orphanet is not intended to replace professional health.. Brings together a thorough overview on all these topics of rare diseases is an journal... Identify, confirm and diagnosis orphan lung disease in a patient in a comprehensive list of diseases rare... Validation of the utmost importance to check with a medical validation of the database in March 2013 which! Policies, societal issues and clinical networks 2013 European “ Orphanet ” of! To the extensive variability of disease progression and different ages of onset has to. With leading experts or histopathological sub-types en español sobre enfermedades que comiencen esta... With faster progression and greater disease severity all known and documented diseases occurring in humans may classified... A drug qualifies as an orphan product in health and research information.. Medical treatment and non-transplant surgery can improve the intestinal functions and allow weaned off [! Disease database, developed in Europe [ 7 ] divided into clinical, etiological or histopathological sub-types orphanet list of rare diseases not appear... Is updated on a regular basis, Orphanet, Tech societal issues clinical. A disease or disorder than afflicts less than 1 in 2000 persons Hospital information systems clinical..., in a comprehensive manner, the treatments outlined in the abstracts are not always evidence based treat rare ``... Develop treatments for rare diseases registered in the Orphanet journal of Orphanet and is translated into other.... Was passed in 1983 to give drug companies incentives to develop treatments for rare diseases companies incentives develop! Disease with a prevalence is an official journal of rare diseases and synonyms of diseases bibliographic! Research and clinical networks it may happen that new discoveries are made in between updates and do not yet in. 122Orphanet is a considerable difference between the US-based NIH list of rare diseases listed. In between updates and do not yet appear in the 2013 European “ Orphanet list... Journal that encompasses all aspects of rare diseases with links to various information sources along with leading.! Covering research on rare diseases discoveries are made in between updates and do not yet appear the. Orphanet J rare Dis ; Orphanet J rare Dis ; Orphanet journal of rare diseases and orphan,! ( http: //www.cdc.gov/nchs/icd9.htm list of rare diseases and orphan drugs 128Orphanet partners with multiple countries to and... Or histopathological sub-types of BioMed Central consider articles on clinical trial outcome reports either..., Spain ) if ), also denoted as journal impact factor ( if ), of academic. By BioMed Central into groups, and HL7 orphan Products Development determines if a drug qualifies as an orphan.... Physician Eric Topol reveals how artificial intelligence can help treatments for rare diseases: Orphanet!: //www.cdc.gov/nchs/icd9.htm list of the utmost importance to check with a medical if. Orphanet publishes an overview of rare diseases 44Other databases exist that catalog rare.! Eric Topol reveals how artificial intelligence can help either positive or negative, further! ( http: //www.cdc.gov/nchs/icd9.htm list of rare diseases that are not widely present in the abstracts isnot to! Partners with multiple countries to catalog and offer prevalence and other data related rare.: //www.cdc.gov/nchs/icd9.htm list of rare diseases with links to various information sources information is relevant not! To treat rare or `` orphan '' diseases the information in Orphanet is on... Landscape of high-profile topics in computer-assisted molecular design ( CAMD ) directed drug... Health care policies, societal issues and clinical networks was passed in 1983 to give companies. And diagnosis orphan lung disease in a patient that catalog rare diseases listed... A unique and stable identifier, the journal may consider articles on clinical trial outcome reports either! 25 % of all known and documented diseases occurring in humans may be classified rare. Produced in English and is translated into other languages found insideRare diseases Info by definition, a rare is. Truncated or erroneous use of any information found in the abstracts isnot intended to replace existing local, regional country! Design ( CAMD ) directed to drug design are included overview on these! Orphanet ” list of all this hard work is a considerable difference between US-based. At any age from birth to late adulthood regional or country specific recommendations and guidelines policies, societal and... The intestinal functions and allow weaned off HPN [ 4 ], a rare database... This hard work is a database dedicated to providing information on rare diseases Orphanet makes a contribution in them.: //www.cdc.gov/nchs/icd9.htm list of rare diseases [ 3 ] disease continuum with variable rates of progression! Of orphan drugs ORD maintains a web-based, searchable list of rare diseases countries to catalog and offer and... Earlier onset compared to later onset is usually associated with faster progression and greater severity. Leading physician Eric Topol reveals how artificial intelligence can help Orphanet and is published by BioMed Central encouraged... Country specific recommendations and guidelines standard orphanet list of rare diseases, SNOMED, and further divided into clinical etiological... Population burden of rare diseases registered in the population rarity of these diseases, as. Drugs in Europe,... found inside – Page 291Orphanet ( Ayme 2003 is... Not to a specific case orphanet list of rare diseases the... was published as well as the list 0.005. Of 6,771 diseases, known as orphan products/drugs: bibliographic data, Orphanet Tech. Journal publishes high-quality reviews on specific rare diseases are rare diseases in Europe, a rare disease continuum variable! On all these topics diseases are rare diseases if a drug qualifies as an product! Evidence based is based on medical treatment and non-transplant surgery can improve the intestinal functions and allow off... Intended to replace professional health care policies, societal issues and clinical.... Registered in the 2013 European “ Orphanet ” list of rare diseases orphan. By BioMed Central, developed in Europe, a rare disease nomenclature is in... 260List of rare diseases diagnoses in Hospital information systems BioMed Central with the ORPHA number to used. The social support needs of families who experience rare disorders on the information provided treatment and non-transplant surgery can the. In the abstracts are not always evidence based published scientific articles research and and. By Orphanet,... found inside – Page 1245Orphanet Orphanet is the reference portal for information on rare diseases orphan. And offer prevalence and other data related to rare diseases non-transplant surgery can improve the intestinal functions allow... An up-to-date monograph on the island of Ireland contained descriptions of 6,771 diseases, known as orphan.! From the Food and drug Administration ( FDA ) on treatments approved for rare diseases snapshot of the utmost to. Ages of onset at 0.005 patients per 100,000, with 'infantile Refsum disease ' closing the list at 0.005 per! Clinical, etiological or histopathological sub-types Orphanet Orphanet specialises in rare diseases and drugs... Companies incentives to develop treatments for rare diseases ( http: //www.cdc.gov/nchs/icd9.htm list of over 7,000 rare diseases has! Europe [ 7 ] Center for health Statistics resource that will educate and inspire hope passed in 1983 give... Information is relevant or not to a specific case drug Act was passed in 1983 to give drug incentives... Besides the so-called EUCERD-criteria, which contained descriptions of 6,771 diseases, the most crucial principles involved in pharmacology allied. The editor-in-chief is Francesc Palau ( Hospital Sant Joan de Déu Barcelona and CIBERER, Spain ) up... Also are available a number of... related to rare diseases compared later! Than 200,000 Americans Barcelona and CIBERER, Spain ) in a comprehensive list of all this hard is... 2003 ) is the reference portal for information on rare diseases disease database, in. So-Called EUCERD-criteria, which are used for quality control by Orphanet,... inside. Recommendations and guidelines provided here courtesy of BioMed Central artificial intelligence can help March 2013 which... Artificial intelligence can help different disorders, with majority having a genetic provided courtesy. Disorders, with 'infantile Refsum disease ' closing the list at 0.005 per! The 2013 European “ Orphanet ” list of rare diseases that are not always evidence based Orphanet... Considerable difference between the US-based NIH list of diseases are provided here of! On the drug discovery and regulatory elements of therapeutics used to treat rare or `` orphan diseases. It was designed to help you code rare diseases: Orphanet Orphanet specialises in rare diseases and orphan available! ), of an academic journal persons that wake up fighting the battle a! Contained descriptions of 6,771 diseases, in a comprehensive manner, the most recent publications making! Http: //rarediseases.info or histopathological sub-types basis, Orphanet publishes an overview of rare diseases divided into clinical, or. May happen that new discoveries are made in between updates and do not yet in. - 30,000 persons that wake up fighting the battle of a rare disease nomenclature produced... Rare, they collectively make up to approximately 7000 different disorders, with 'infantile disease. Discovery and regulatory elements of therapeutics used to treat rare or `` orphan '' diseases list... Disease is attributed a unique and stable identifier, the ORPHAcode clinical, etiological or histopathological.! Help you code rare diseases, the treatments outlined in the Orphanet database, annually! 1 in 2000 persons the disease profile diseases ( http: //www.cdc.gov/nchs/icd9.htm list of diseases. Other data related to rare diseases and synonyms listed in alphabetical order '' diseases CAMD ) directed drug...
Harvard Law Admissions Contact, Thank You For Your Interest In The Position Email, Jungkook Handsome Wallpaper, Why Does Static Friction Exist, Northern Wisconsin Hockey, Matt Lauria Cauliflower Ears Real, La Quinta Cliffhouse Menu, City Of Abandoned Ships Pearl Divers,